Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Shiun Chen

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Pharmacogenomics|June 20, 2018
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessationNaji C Salloum, Erica L F Buchalter, Swati Chanani, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Schizophrenia Research|March 13, 2017
Genetic correlation between smoking behaviors and schizophreniaSarah M Hartz, Amy C Horton, Dana B Hancock, et al.
Genetic Epidemiology|August 18, 2020
Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzymeMichael J Bray, Li-Shiun Chen, Louis Fox, et al.
Frontiers in Public Health|June 30, 2020
Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer CentersHeather D'Angelo, Alex T Ramsey, Betsy Rolland, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Genomic Insights for Personalized Care: Motivating At-Risk Individuals Toward Evidence-Based Health PracticesTony Chen, Giang Pham, Louis Fox, et al.
Ebiomedicine|November 9, 2024
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practicesTony Chen, Giang Pham, Louis Fox, et al.
Implementation Science Communications|April 10, 2021
Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centersRamzi G Salloum, Heather D'Angelo, Ryan P Theis, et al.
Addiction Biology|December 30, 2016
CYP2A6 metabolism in the development of smoking behaviors in young adultsEmily Olfson, Joseph Bloom, Sarah Bertelsen, et al.
Pharmacopsychiatry|November 4, 2020
Review and Consensus on Pharmacogenomic Testing in PsychiatryChad A Bousman, Susanne A Bengesser, Katherine J Aitchison, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Pharmacogenomics|June 20, 2018
From genes to treatments: a systematic review of the pharmacogenetics in smoking cessationNaji C Salloum, Erica L F Buchalter, Swati Chanani, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 3, 2016
Task-related fMRI responses to a nicotinic acetylcholine receptor partial agonist in schizophrenia: A randomized trialDeanna M Barch, Stephen R Marder, Michael P Harms, et al.
Schizophrenia Research|March 13, 2017
Genetic correlation between smoking behaviors and schizophreniaSarah M Hartz, Amy C Horton, Dana B Hancock, et al.
Genetic Epidemiology|August 18, 2020
Dissecting the genetic overlap of smoking behaviors, lung cancer, and chronic obstructive pulmonary disease: A focus on nicotinic receptors and nicotine metabolizing enzymeMichael J Bray, Li-Shiun Chen, Louis Fox, et al.
Frontiers in Public Health|June 30, 2020
Pragmatic Application of the RE-AIM Framework to Evaluate the Implementation of Tobacco Cessation Programs Within NCI-Designated Cancer CentersHeather D'Angelo, Alex T Ramsey, Betsy Rolland, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Genomic Insights for Personalized Care: Motivating At-Risk Individuals Toward Evidence-Based Health PracticesTony Chen, Giang Pham, Louis Fox, et al.
Ebiomedicine|November 9, 2024
Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practicesTony Chen, Giang Pham, Louis Fox, et al.
Implementation Science Communications|April 10, 2021
Mixed-methods economic evaluation of the implementation of tobacco treatment programs in National Cancer Institute-designated cancer centersRamzi G Salloum, Heather D'Angelo, Ryan P Theis, et al.
Addiction Biology|December 30, 2016
CYP2A6 metabolism in the development of smoking behaviors in young adultsEmily Olfson, Joseph Bloom, Sarah Bertelsen, et al.
Pharmacopsychiatry|November 4, 2020
Review and Consensus on Pharmacogenomic Testing in PsychiatryChad A Bousman, Susanne A Bengesser, Katherine J Aitchison, et al.
Pageof 10